IMAGING IN THYROID CANCER
- 1 March 1996
- journal article
- Published by Elsevier in Endocrinology and Metabolism Clinics of North America
- Vol. 25 (1) , 93-113
- https://doi.org/10.1016/s0889-8529(05)70314-5
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Somatostatin receptor imaging in persistent medullary thyroid carcinomaClinical Endocrinology, 1995
- Clinical utility of posttreatment radioiodine scans in the management of patients with thyroid carcinomaJournal of Clinical Endocrinology & Metabolism, 1994
- The role of iodine-131 and thallium-201 imaging and serum thyroglobulin in the management of differentiated thyroid carcinomaCancer, 1993
- The potential value of somatostatin receptor scintigraphy in medullary thyroid carcinomaNuclear Medicine Communications, 1993
- Validation of Somatostatin Receptor Scintigraphy in the Localization of Neuroendocrine TumorsActa Oncologica, 1993
- Positron Emission Tomography of Thyroid MassesThyroid®, 1993
- Imaging of medullary carcinoma of the thyroid using 111In-labelled anti-CEA monoclonal antibody fragmentsNuclear Medicine Communications, 1992
- Gallium-67 Imaging in the Evaluation of Thyroid MalignancyClinical Nuclear Medicine, 1988
- Cystic change and neoplasia in isolated thyroid swellingsBritish Journal of Surgery, 1988
- New Radionuclide Tracers for the Diagnosis and Therapy of Medullary Thyroid CarcinomaClinical Nuclear Medicine, 1988